Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Nazan YURTCU"'
Autor:
Nazan YURTCU, Aylin GÖKHAN
Publikováno v:
Ahi Evran Medical Journal, Vol 7, Iss 1, Pp 6-12 (2023)
Purpose: We aimed to investigate the antitumor activity of NMS-P937, a specific small-molecule polo-like kinase 1 (PLK1) inhibitor, in PC3 human prostate cancer, HeLa cervical cancer, and SKOV-3 ovarian cancer cell lines. Materials and methods: PC3,
Externí odkaz:
https://doaj.org/article/04f8232c093243f5aa8fc36157f2a91b
Publikováno v:
Medicine Science, Vol 12, Iss 1, Pp 20-5 (2023)
Cervical and ovarian cancer are two aggressive neoplasms for women, still with high mortality and morbidity. Among the molecules and compounds that have anticancer activity, it was studied the JG-98, a heat shock protein 70 (HSP70) inhibitor. It demo
Externí odkaz:
https://doaj.org/article/277dc7e871b24322a3388d42c49d6f77
Publikováno v:
Zeitschrift für Geburtshilfe und Neonatologie. 226:384-390
Objective We aimed to examine the predictive and prognostic value of plasma zonulin for gestational diabetes mellitus (GDM) in women at 24–28 weeks of gestation. Methods This retrospective study was carried out with pregnant women with GDM (n=98) a
Autor:
Filiz Yarsilikal Guleroglu, Esra Selvi, Isil Turan Bakirci, Olgu Bafalı, Hatice Argun Atalmis, Merve Yasti Dayan, Aliye Balkan Ozmen, Nazan Yurtcu, Busra Seker Atas, Esma Ozdemir Anayurt, Ali Cetin
Aims We evaluated the clinical value of selected serum biomarkers BMP-4, BMP-2, GDF-15, MMP-9, and GP39 in pregnant women with obesity and the comorbidities diabetes mellitus (DM) and gestational hypertension (GHT). Methods This observational study h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96624573816587b8ef0674c86cd15147
https://hdl.handle.net/20.500.12418/14003
https://hdl.handle.net/20.500.12418/14003
Autor:
Canan Soyer Caliskan, Nazan Yurtcu, Samettin Celik, Ozlem Sezer, Suleyman Sirri Kilic, Ali Cetin
Publikováno v:
Journal of Obstetrics and Gynaecology. 42:2105-2114
Balanced vaginal microbiota and, as a continuum, cervical canal microbiota help prevent reproductive disorders, including recurrent miscarriage (RM). In a significant proportion of couples with RM, routine diagnostic workup cannot find any manageable
Publikováno v:
Turkish journal of obstetrics and gynecology. 19(4)
Objective: Pre-eclampsia (PE), a pregnancy-specific syndrome consisting of hypertension and proteinuria occurring de novo after the 20th week of gestation, remains the leading cause of maternal and fetal morbidity and mortality worldwide. Endothelial
Autor:
Michael H. Dahan, Murat Alagoz, Sebahattin Celik, Serkan Oral, Suleyman Tumer Calıskan, Nazan Yurtcu
Publikováno v:
Journal of Obstetrics and Gynaecology Research. 48:178-187
We aimed to investigate the value of follicular fluid fetuins-A and -B to predict successful IVF and pregnancy outcomes in infertile women with poor, normal, and high ovarian reserve.The follicular fluid of 96 infertile women who underwent intra-cyto
Autor:
Bahadir, Yazicioglu, Nazan, Yurtcu, Huri, Guvey, Canan, Soyer Caliskan, Samettin, Celik, Andrea, Tinelli
Publikováno v:
Ginekologia Polska.
Poor overall neonatal outcomes, small neonatal head circumference, neonatal hypoglycemia, need for Neonatal Intensive Care Unit and late-onset neonatal sepsis are more common in adolescents. The aim of this study is to draw attention to the outcomes
Autor:
Handan Celik, Nazan Yurtcu, Mehmet Güçlü, Canan Soyer Çalişkan, Samettin Çelik, Safak Hatirnaz
Publikováno v:
Journal of Experimental and Clinical Medicine. 38:594-598
The primary objectives of this study were to evaluate the impact of intramuscular meperidine on shortening of the active phase of labor, the neonatal outcome and the rate and severity of perineal lacerations in term pregnant women in the first stage
Autor:
Aylin Gökhan, NAZAN YURTCU
Publikováno v:
Ahi Evran Medical Journal.
Objectives: We aimed to investigate the antitumor activity of NMS-P937, a specific small-molecule polo-like kinase 1 (PLK1) inhibitor, in PC3 human prostate cancer, HeLa cervical cancer, and SKOV-3 ovarian cancer cell lines. Methods: PC3, HeLa, and S